Problem is, this article states that "First, the FDA acknowledges that while Pfizer has “insufficient stocks” of the newly licensed Comirnaty vaccine available, there is “a significant amount” of the Pfizer-BioNTech COVID vaccine —". The FDA stated that they approved the Pfizer-BioNTech vaccine, and it is now marketed as Comirnaty.
Problem is, this article states that "First, the FDA acknowledges that while Pfizer has “insufficient stocks” of the newly licensed Comirnaty vaccine available, there is “a significant amount” of the Pfizer-BioNTech COVID vaccine —". The FDA stated that they approved the Pfizer-BioNTech vaccine, and it is now marketed as Comirnaty.